PRKAR1A and cancer: To confirm the presence of the PRKAR1A mutations and better assess the VAFs for these alterations, targeted sequencing was carried out on the same lesional DNA using pools of multiplex primers from the Ion AmpliSeqTM Comprehensive Cancer Panel that separately covered the regions of the mutations within the gene.